Tissue Factor Pathway Inhibitor Inhibits Endothelial Cell Proliferation via Association with the Very Low Density Lipoprotein Receptor

This publication has 36 references indexed in Scilit:

• Apolipoprotein(a), a Link between Atherosclerosis and Tumor Angiogenesis
  Biochemical and Biophysical Research Communications, 1999
• Interaction of Cytosolic Adaptor Proteins with Neuronal Apolipoprotein E Receptors and the Amyloid Precursor Protein
  Journal of Biological Chemistry, 1998
• The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor.
  Journal of Clinical Investigation, 1997
• The Endothelial Cell Protein C Receptor
  Journal of Biological Chemistry, 1996
• Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.
  Journal of Clinical Investigation, 1995
• The Very Low Density Lipoprotein Receptor Mediates the Cellular Catabolism of Lipoprotein Lipase and Urokinase-Plasminogen Activator Inhibitor Type I Complexes
  Published by Elsevier ,1995
• Apolipoprotein E: A potent inhibitor of endothelial and tumor cell proliferation
  Journal of Cellular Biochemistry, 1994
• Cloning of a cDNA encoding a putative human very low density lipoprotein/apolipoprotein E receptor and assignment of the gene to chromosome 9pter-p23
  Somatic Cell and Molecular Genetics, 1993
• Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
  Neuron, 1993
• The human alpha 2-macroglobulin receptor: identification of a 420-kD cell surface glycoprotein specific for the activated conformation of alpha 2-macroglobulin.
  The Journal of cell biology, 1990